Xinya Li
Chongqing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
The ratio of effect-based combination indexes can indicate nonapoptotic cell-death in a combined cancer therapy.
Journal: Frontiers in pharmacology
Published: November 01, 2025
Evaluations of Dose-effect Curves and Half-maximal Effective Doses Using the Four-parameter Logistic Model: When are Results Reliable?
Journal: Current neuropharmacology
Published: September 16, 2025
Prodrug-carboxypeptidase G2 therapy: certain concerns on carboxypeptidase G2.
Journal: Frontiers in pharmacology
Published: January 15, 2025
Determining the Interaction in a Drug Combination using the Dose-based or Effect-based Method.
Journal: Current neuropharmacology
Published: June 26, 2024
LPCAT3 regulates the proliferation and metastasis of serous ovarian cancer by modulating arachidonic acid.
Journal: Translational oncology
Published: May 14, 2024
Intracellular Pharmacokinetics of Activated Drugs in a Prodrug-Enzyme-Ultrasound System: Evaluations on ZD2767P+CPG2+US.
Journal: ACS medicinal chemistry letters
Published: February 08, 2024
Clinical Trials of High-intensity Focused Ultrasound for Cancer: Concerns Arising from Low Post-Hoc Power.
Journal: Current medicinal chemistry
Published: September 12, 2023
Development of ZD2767P-carboxypeptidase G2-ultrasound therapy against cisplatin-resistant cancer.
Journal: Frontiers in oncology
Published: January 26, 2023
IDO1 Modulates the Sensitivity of Epithelial Ovarian Cancer Cells to Cisplatin through ROS/p53-Dependent Apoptosis.
Journal: International journal of molecular sciences
Published: September 14, 2022
Ultrasonically Enhanced ZD2767P-Carboxypeptidase G2 Deactivates Cisplatin-Resistant Human Lung Cancer Cells.
Journal: Oxidative medicine and cellular longevity
Published: January 11, 2022
Thioridazine Enhances Cisplatin-Induced DNA Damage in Cisplatin-Resistant Human Lung Cancer Cells.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: December 07, 2021
NTNG1 Modulates Cisplatin Resistance in Epithelial Ovarian Cancer Cells via the GAS6/AXL/Akt Pathway.
Journal: Frontiers in cell and developmental biology
Published: January 12, 2021
Last Updated: 09/26/2026